Amarantus Bioscience Holdings Inc (AMBS)

[MagicCap]

We can only lead the horse to water. We can't make it drink. We get a little selling in a 2 hour span after a 500% move up and all of the sudden its dilution and the Michael j fox foundation thinks MANF data isn't positive. Funny stuff. The patient ones here like smoke_em, aewilliamson, lewsogge and me will make out like bandits here because we know the facts will win out:

+CSO is a world reknown Scientist and former head of Neurotrophic Factors at NIH and professor at world reknown McGill University): https://www.michaeljfox.org/foundation/researchers.php?id=1015 (notice where this link goes to?)
+Money poured into GDNF at same stage of testing (which has had worse results than MANF) ~ $250 Million
+GDNF had issues with poor diffusion rates and had issues with binding heparin with high affinity both of which aren't characteristics of MANF
+Money poured into Neurturin, another protein in the class of neurotrophic factors, which is in stage I ~ $150 Million
+Patent protection - upheld in court vs Hermo Pharma, a VC backed and MJFF funded biotech firm
+A partner at Hermo Pharma even admitted that the company's MANF patents cause "an undue burden on anyone trying to test MANF because it covers anything with a 90% homology (ie similarity) to MANF: http://m.seekingalpha.com/instablog/167303-jonathan-verenger/1348791-exciting-field-in-cure-for-parkinson-s
+Founder of Amgen believes it could be the biggest success he has ever seen. He is also presenting alongside the CSO on 1/8/13 in front of a crowd of Pharma companies and VC investors about the commercial opportunities that exist for MANF.

AMBS is an EPIC Stock. EPIC Stocks can be found once every 5 years or so. They go up several hundred fold over the span of 6 to 12 months because their potential is so much greater than the market realized and it collectively comes to an aha moment. For people like us who got in and hold from the .02 to .03 level we will net a 20 to 60 bagger. 99.99% of investors lack patience to hold throughout.. The patient ones will make out like bandits. Bashers/impatient investors will continue to watch it go higher in disbelief that they sold or never got in when it was staring them right in their eyes.

Stars are aligned for a move to $0.40+ shortly. The market cap at $23 million is way too small for this company given the above facts. We will continue to go higher much to the chagrin of every naysayer / disbeliever.